Search research articles
Contact Us
Filters
Showing results (91-100 of 161) with videos related to
Page
of 17
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
Factors associated with bacteraemia in febrile, granulocytopenic cancer patients. The International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC)
C Viscoli, P Bruzzi, E Castagnola, et al.
Cancer
|
September 1, 1986
Hypercoagulable state induced by cytostatic drugs in stage II breast cancer patients
L Canobbio, T Fassio, A Ardizzoni, et al.
Neurology
|
November 28, 2001
Sample size estimations for MRI-monitored trials of MS comparing new vs standard treatments
M P Sormani, M Rovaris, F Bagnato, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1990
Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, estrogen receptor-positive breast cancer patients: results of a multicentric Italian study. Breast Cancer Adjuvant Chemo-Hormone Therapy Cooperative Group
F Boccardo, A Rubagotti, P Bruzzi, et al.
American Journal of Clinical Oncology
|
August 1, 1994
Randomized study comparing chemotherapy plus radiotherapy versus radiotherapy alone in FIGO stage IIB-III cervical carcinoma. GONO (North-West Oncologic Cooperative Group)
S Chiara, M Bruzzone, L Merlini, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
February 25, 2000
Phase II study of combined immunotherapy, chemotherapy, and radiotherapy in the postoperative treatment of advanced non-small-cell lung cancer
G B Ratto, M A Cafferata, T Scolaro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 5, 1999
Cardiotoxicity of epirubicin/paclitaxel-containing regimens: role of cardiac risk factors
A Gennari, B Salvadori, S Donati, et al.
Annali Dell'Istituto Superiore Di Sanita
|
January 1, 1992
[Survival in respiratory tract tumors: Italian population-based data and international comparisons]
A Micheli, A Baldasseroni, P Bruzzi, et al.
British Journal of Cancer
|
March 5, 2004
Activity of first-line epirubicin and paclitaxel in metastatic breast cancer is independent of type of adjuvant therapy
A Gennari, P Bruzzi, C Orlandini, et al.
Minerva Chirurgica
|
June 30, 1986
[Clinico-microbiological investigation in septic complications after gastrointestinal surgery. A multicenter study]
M Battezzati, E Berti Riboli, F Cafiero, et al.
Page
of 17
Search research articles
Search
Showing results (91-100 of 161) with videos related to
Sort By:
Page
of 17
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
Factors associated with bacteraemia in febrile, granulocytopenic cancer patients. The International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC)
C Viscoli, P Bruzzi, E Castagnola, et al.
Cancer
|
September 1, 1986
Hypercoagulable state induced by cytostatic drugs in stage II breast cancer patients
L Canobbio, T Fassio, A Ardizzoni, et al.
Neurology
|
November 28, 2001
Sample size estimations for MRI-monitored trials of MS comparing new vs standard treatments
M P Sormani, M Rovaris, F Bagnato, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1990
Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, estrogen receptor-positive breast cancer patients: results of a multicentric Italian study. Breast Cancer Adjuvant Chemo-Hormone Therapy Cooperative Group
F Boccardo, A Rubagotti, P Bruzzi, et al.
American Journal of Clinical Oncology
|
August 1, 1994
Randomized study comparing chemotherapy plus radiotherapy versus radiotherapy alone in FIGO stage IIB-III cervical carcinoma. GONO (North-West Oncologic Cooperative Group)
S Chiara, M Bruzzone, L Merlini, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
February 25, 2000
Phase II study of combined immunotherapy, chemotherapy, and radiotherapy in the postoperative treatment of advanced non-small-cell lung cancer
G B Ratto, M A Cafferata, T Scolaro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 5, 1999
Cardiotoxicity of epirubicin/paclitaxel-containing regimens: role of cardiac risk factors
A Gennari, B Salvadori, S Donati, et al.
Annali Dell'Istituto Superiore Di Sanita
|
January 1, 1992
[Survival in respiratory tract tumors: Italian population-based data and international comparisons]
A Micheli, A Baldasseroni, P Bruzzi, et al.
British Journal of Cancer
|
March 5, 2004
Activity of first-line epirubicin and paclitaxel in metastatic breast cancer is independent of type of adjuvant therapy
A Gennari, P Bruzzi, C Orlandini, et al.
Minerva Chirurgica
|
June 30, 1986
[Clinico-microbiological investigation in septic complications after gastrointestinal surgery. A multicenter study]
M Battezzati, E Berti Riboli, F Cafiero, et al.
Page
of 17